Objective
=========

We investigated whether there is a link between two markers for Crohn\'s disease (CD): the CD susceptibility mutations in the CARD15 gene and the serologic anti-*Saccharomyces cerevisiae* (ASCA) antibodies. Both markers may, in some way, also be associated with spondyloarthropathy (SpA), which is known to be related to inflammatory bowel disease.

Methods
=======

Serum samples of 109 CD patients were analysed for IgA and IgG ASCA with a commercial ELISA kit. A RFLP-PCR technique was used to genotype all patients for three single-nucleotide polymorphisms (SNPs) in the CARD15 gene: R702W, G908R and 1007 fs. Every SNP was verified by direct sequencing.

Results
=======

The overall carrier frequency of a CARD15 mutation in CD was 50.5%. ASCA-positivity for IgA, IgG and IgG or IgA was found in respectively 31.2%, 31.2% and 43.1%.

Chi-square testing showed a positive association between CARD15 mutation and ASCA IgA (*P* = 0.001, OR = 4.167, CI 1.709--10.157), IgG (*P* = 0.005, OR = 3.406, CI 1.428--8.124) and IgA or IgG (*P* = 0.005, OR = 3.068, CI 1.391--6.764).

Conclusion
==========

CARD15 mutations and ASCA are not independent risk factors for CD. Instead, they are significantly associated with each other in a population of CD patients (both for ASCA IgA and IgG isotype). This could be interpreted in a double way. CARD15 mutations and ASCA may be both associated with a particular, as-yet-undefined, phenotypic subset of CD. Or CARD15, as an immune-response gene, may in some way modulate humoral immunity, predisposing to the generating of ASCA.
